These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8462025)

  • 1. A model for others: a strategy for improving diagnosis and therapy of human malignancies using monoclonal antibodies targeting TAG-72 oncofetal antigen.
    Larson SM
    Cancer Invest; 1993; 11(2):235-8. PubMed ID: 8462025
    [No Abstract]   [Full Text] [Related]  

  • 2. A simple method to determine the immunoreactivity of radiolabelled monoclonal antibodies to the TAG-72 antigen.
    Ngai WM; Reilly RM
    Appl Radiat Isot; 1993 Sep; 44(9):1193-7. PubMed ID: 8401449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary antibodies as tools to improve tumor to non tumor ratio at radioimmunolocalisation and radioimmunotherapy.
    Ullén A; Ahlström KR; Heitala S; Nilsson B; Arlestig L; Stigbrand T
    Acta Oncol; 1996; 35(3):281-5. PubMed ID: 8679257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the pretargeting approach to image and treat tumours.
    Patra M; Zarschler K; Pietzsch HJ; Stephan H; Gasser G
    Chem Soc Rev; 2016 Nov; 45(23):6415-6431. PubMed ID: 27722526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunodetection and radioimmunotherapy of head and neck cancer.
    Börjesson PK; Postema EJ; de Bree R; Roos JC; Leemans CR; Kairemo KJ; van Dongen GA
    Oral Oncol; 2004 Sep; 40(8):761-72. PubMed ID: 15288829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretargeting strategies for radio-immunoguided tumour localisation and therapy.
    Stoldt HS; Aftab F; Chinol M; Paganelli G; Luca F; Testori A; Geraghty JG
    Eur J Cancer; 1997 Feb; 33(2):186-92. PubMed ID: 9135486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunotherapy of solid tumors: from fairytale to reality.
    Adams GP; Weiner LM
    Cancer Biother Radiopharm; 2001 Feb; 16(1):9-11. PubMed ID: 11279802
    [No Abstract]   [Full Text] [Related]  

  • 8. Radioimmunodiagnosis and therapy.
    Verhaar-Langereis MJ; Zonnenberg BA; de Klerk JM; Blijham GH
    Cancer Treat Rev; 2000 Feb; 26(1):3-10. PubMed ID: 10660488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4th Scandinavian Symposium on Radiolabeled Monoclonal Antibodies in Diagnosis and Therapy of Cancer. Lillehammer, Norway, January 15-17, 1995.
    Acta Oncol; 1996; 35(3):257-390. PubMed ID: 8679253
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic applications and therapeutic approaches with different preparations of anti-CEA antibodies.
    Bischof Delaloye A; Delaloye B
    Int J Biol Markers; 1992; 7(3):193-7. PubMed ID: 1431345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preselection of patients with high TAG-72 antigen expression leads to targeting of 94% of known metastatic tumor sites with monoclonal antibody I-131-CC49.
    Kostakoglu L; Divgi CR; Hilton S; Cordon-Cardo C; Scott AM; Kalaigian H; Finn RD; Schlom J; Larson SM
    Cancer Invest; 1994; 12(6):551-8. PubMed ID: 7994589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radioimmunotargeting: diagnosis and therapeutic use].
    Vuillez JP
    Bull Cancer; 2000 Nov; 87(11):813-27. PubMed ID: 11125290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of radiolabeled monoclonal antibodies for diagnosis and therapy of cancer.
    Divgi CR
    Oncology (Williston Park); 1996 Jun; 10(6):939-53; discussion 954, 957-8. PubMed ID: 8823804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
    Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Begent RH
    Cancer Biother Radiopharm; 2001 Oct; 16(5):391-400. PubMed ID: 11776756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoclonal antibodies. An approach to diagnosis and treatment of micrometastases].
    Bier H
    HNO; 1994 May; 42(5):255-6. PubMed ID: 8050912
    [No Abstract]   [Full Text] [Related]  

  • 16. The current status of radiolabeled monoclonal antibodies for the diagnosis and treatment of human malignancies.
    Kuzel TM; Duda RB
    Compr Ther; 1992 Jun; 18(6):16-20. PubMed ID: 1511591
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.
    Rogers BE; Roberson PL; Shen S; Khazaeli MB; Carpenter M; Yokoyama S; Brechbiel MW; LoBuglio AF; Buchsbaum DJ
    Cancer Biother Radiopharm; 2005 Oct; 20(5):502-13. PubMed ID: 16248766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: what ails solid tumor radioimmunotherapy?
    Divgi C
    Cancer Biother Radiopharm; 2006 Apr; 21(2):81-4. PubMed ID: 16706627
    [No Abstract]   [Full Text] [Related]  

  • 19. Pre-targeted radioimmunotherapy of human colon cancer xenografts in athymic mice using streptavidin-CC49 monoclonal antibody and 90Y-DOTA-biotin.
    Domingo RJ; Reilly RM
    Nucl Med Commun; 2000 Jan; 21(1):89-96. PubMed ID: 10717908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoscintigraphy and radioimmunotherapy in Cuba: experiences with labeled monoclonal antibodies for cancer diagnosis and treatment (1993-2013).
    Peña Y; Perera A; Batista JF
    MEDICC Rev; 2014; 16(3-4):55-60. PubMed ID: 25208121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.